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Lack of association between the CC genotype 
of the rs7903146 polymorphism in the 
TCF7L2 gene and rheumatoid arthritis
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ABSTRACT
Introduction: TCF7L2 is a transcription factor involved in Wnt/beta-catenin signaling and which has a variant known 
to be consistently associated with type 2 diabetes risk and some studies have also indicated its association with risk of 
certain types of cancer. Objective: Since this pathway may be involved in the pathophysiology of other chronic infl am-
matory diseases such as rheumatoid arthritis, we aimed to investigate the effect of TCF7L2 polymorphism rs7903146 on 
rheumatoid arthritis severity in a Brazilian population. Patients and methods: This polymorphism was genotyped in 208 
patients with rheumatoid arthritis and in 104 healthy controls. We also analyzed the association of this polymorphism to 
smoking history, functional status classifi cation and radiological indicators of disease severity. Results: The distribution 
of CC, CT and TT genotypes of SNP rs7903146 of the TCF7L2 gene was not different between patients and controls, 
and no association between the genotype and indicators of disease severity or smoking history was found. When data 
were evaluated using the dominant model, in which carriers of the CT and TT genotypes were grouped, an increase in 
the T allele was observed in patients positive for rheumatoid factor and erosions, although this was not signifi cant. The 
frequency of T allele was also increased in patients with functional class II compared to class I (P = 0.032). Conclusion: It 
is possible that the small number of patients included in this study may have restrained additional fi ndings. Further studies 
are therefore needed to investigate the role of TCF7L2 gene variants in the risk of rheumatoid arthritis and its severity.
Keywords: Wnt proteins, genetics, polymorphism, genetic.
© 2012 Elsevier Editora Ltda. All rights reserved.
INTRODUCTION
Rheumatoid Arthritis (RA) is a progressive and chronic sys-
temic infl ammatory disease of unknown etiology. It involves 
primarily the synovial membrane, and can lead to the destruc-
tion of bone and cartilage.1 RA affects about 0.5%–1% of the 
world population; this fi gure can reach up to 5% depending 
on the age and ethnic group studied.2
Despite signifi cant advances in the treatment of RA in the last 
few decades due to the development of appropriate laboratory 
and imaging methods, such methods still have a limited value 
for the early diagnosis of RA and also for the defi nition of an 
individual prognosis, and these aspects may limit the therapeutic 
effect of available medications.3 A better understanding of the 
physiopathological factors related to this disease would be of 
great value in establishing early and effective treatment.
A number of studies have emphasized the critical role of 
activated fi broblast-like synovial cells (FLS) in the pathogenesis 
of RA, since a hyperplastic FLS population could potentially 
promote leukocyte infi ltration and retention.4 The rheumatoid 
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synovium eventually turns into a pannus that destroys the articu-
lar cartilage and bone.4 The underlying mechanisms involved in 
FLS activation are still unknown. It has been suggested that the 
Wingless MMTV-integration site (Wnt) – Frizzled (Fz) signaling 
pathways could be important in autonomous FLS activation.4
In fact, genes encoding proteins in the Wnt-Fz signaling 
pathway are highly expressed in synovial tissues in RA.4 Wnt 
is a family of secreted glycoproteins that bind to cell surface 
G-protein coupled receptors from Fz family to induce intracel-
lular cascades involved in cell growth and differentiation.5 It has 
recently been suggested that these cascades could also contribute 
to initiate an activated FLS phenotype in a process of cell main-
tenance after joint injury,6 and that untimely activation of FLS 
cells could lead to accumulation of activated kinases and tran-
scription and growth factors that could drive RA pathogenesis.5
Two different Wnt-Fz pathways are recognized, that are 
known as the canonical (or β-catenin-dependent) and non-
canonical (or β-catenin-independent) signaling pathways.5 
One of the proteins in the intracellular cascades activated by 
β-catenin-dependent signaling is transcription factor-7-like 2 
(TCF7L2), which has recently been the focus of various studies 
on human diseases, since some common variants of TCF7L2 
gene have been associated with the risk of developing type 2 
diabetes (T2D)6 and certain types of cancer.7–9
TCF7L2 encodes TCF4, a transcription factor involved in the 
Wnt/β-catenin signaling pathway; it has a critical role in embryo-
genesis and in control of cell proliferation and differentiation, and 
it is also involved in diverse physiological processes in adult life.10 
Recently, the rs7903146 polymorphism in the TCF7L2 gene has 
been associated with the risk of developing T2D, possibly through 
impairment of pancreatic beta cells function.11–14 Recently, 
a strong correlation between the T allele of the rs7903146 
polymorphism in the TCF7L2 gene and T2D was described in 
Denmark, the United States and Iceland.7,15 This same correlation 
has been verifi ed in other populations, including those of East 
Asia, Europe, West Africa and Scandinavia.16–19 This genetic 
variant has also been associated with the risk of malignant 
neoplasms of prostate,20 colon,8 and breast.9
There are still data that suggest involvement of the Wnt 
pathway in the infl ammatory response and in the physiopathol-
ogy of chronic infl ammatory disease, which is the case for RA.4 
The Wnt/Fz complex is responsible for controlling the tissue 
formation in embryogenesis and during limb development and 
joint formation.4 Sen et al.21 have studied the role of one of the 
receptor-ligand pairs of Wnt-Fz signaling pathway, namely Wnt-
5A and Fz5, in FLS activation, which results in the production of 
infl ammatory and chemotactic cytokines in the joints of patients 
with RA. The blocking of Wnt-5A/Fz5 signaling diminishes 
IL6 and IL15 induced cytokine expression, such as RANKL, 
and even diminishes synovial activation.21 Another study dem-
onstrated that the activation of Wnt signaling in chondrocytes 
induces degradation of the cartilage matrix, which is similar to 
what occurs in osteoarthritis and rheumatoid arthritis.22 Various 
studies have suggested that Wnt signaling increases bone forma-
tion by regulating the proliferation and differentiation of osteo-
blasts and osteoclasts.23 Moreover, Wnt signaling can promote 
upregulation of osteoprotegerin expression in the osteoblasts. As 
osteoprotegerin inhibits osteoclast differentiation, the signaling 
can partially increase bone mass by blocking bone reabsorption 
through the osteoclasts.23
The activation of the immune system before the beginning 
of the clinical manifestations of the disease suggests that clini-
cal RA already represents a chronic illness. Studies show that 
the earliest possible treatment of auto-immune diseases, before 
the development of disease manifestations, can delay disease 
progression and improve the patient’s prognosis.24,25 In this 
way, genes that codify proteins of the Wnt signaling pathway 
represent plausible candidates whose variants could be related 
to the risk of development of the disease or to its severity.
The mechanisms that underlie the association of TCF7L2 
polymorphisms with T2D and malignant neoplasms risk are still 
unclear. Considering that these diseases have in common with RA 
an infl ammatory response component, and considering the role 
of the Wnt-Fz signaling pathway in this response, the investiga-
tion of the frequency of TCF7L2 common variants in systemic 
infl ammatory diseases like RA could contribute to improve the 
understanding of the mechanisms involved in increased disease 
risk in situations of abnormal TCF7L2 gene expression.26 Given 
these possible benefi ts, a case-control study was proposed to as-
sess the association between the single nucleotide polymorphism 
rs7903146 of TCF7L2 gene and RA activity.
PATIENTS AND METHODS
Patients
After approval from the Ethics Research Committee of the 
Universidade de Brasília (CEP/UnB), the selected patients 
were informed about the content and objectives of the study, 
expected benefi ts, freedom of refusal, and the guarantee of 
confi dentiality and privacy. Those who agreed to participate 
signed a free and informed consent form.
A total of 208 patients, which represents the number of patients 
with RA that attend the Rheumatoid Arthritis Clinic at Hospital 
Universitário de Brasília, were selected by convenience for the 
study; they met the classifi catory criteria for the disease according 
to the American College of Rheumatology (ACR 1987).
Mota et al.
520 Rev Bras Reumatol 2012;52(4):518-528
The following patient information was obtained from a 
questionnaire or retrospectively by chart review: age, gender, 
personal history of T2D, smoking history, age at RA diagnosis, 
time since RA diagnosis and functional status classifi cation. 
The results of rheumatoid factor measurement in serum were 
also obtained by review of medical records; in all cases rheu-
matoid factor was measured by nephelometry and values above 
15 UI/mL were considered positive. 
Radiographic information was also obtained, and included 
the presence of erosion in the x-rays of patients’ hands, wrists, 
feet and ankles. Members of the Radiology Team of Hospital 
Universitário de Brasília, who routinely assess these exams, 
evaluated the images.
Collection, purifi cation and DNA genotyping
A 5-mL sample of venous blood was obtained from a periph-
eral vein puncture using disposable material, and the blood 
was stored in bottles that contained EDTA. The sample was 
collected during a visit to the clinic or laboratory.
DNA was extracted from the samples through the Chelex-100 
method27 and genotyping of the rs7903146 polymorphism was 
conducted through an allele-specifi c polymerase chain reaction (AS-
PCR); the primers and conditions have been previously described.28
Statistical analysis
The data obtained were submitted to appropriate statistical testing. 
The measures of smoking, rheumatoid factor, erosions, and func-
tional class were described in the patients from a polymorphism 
analysis with the use of absolute and relative frequencies. The 
testing verifi ed the presence of polymorphism association with 
measures that utilized chi-squared tests or likelihood ratio tests.29 
The chi-squared test was used to assess if the observed genotype 
frequency was consistent with Hardy-Weinberg equilibrium. 
Logistic regression models were implemented for each one of the 
following data, with age and gender controls: smoking history, 
functional class status and radiographic erosions. The models also 
estimated the odds ratio with the respective 95% confi dence inter-
vals.30 Statistically signifi cant values were considered at P < 0.05.
RESULTS
A total of 208 patients with the diagnosis of RA were included. 
Their mean age was 51.55 ± 13.19 years, and most were female 
(87.5%). The mean age at diagnosis was 37.3 years, and the mean 
disease duration, assessed by time since diagnosis, was 8.1 years.
The distribution of TCF7L2 rs7903146 genotype was 
47.6% CC, 45.2% CT and 7.2% TT, and was in agreement with 
Hardy-Weinberg equilibrium. This resulted in the following 
allele frequencies: 70.2% C allele and 29.8% T allele (Table 1).
Statistical differences were not observed between the CC, 
CT, and TT genotypes and the following indicators of rheuma-
toid disease severity: smoking (P = 0.691), rheumatoid factor 
(P = 0.418), erosions (P = 0.261), and functional classes I, II, 
III, and IV (P = 0.328) (Table 2).
Table 1 
Genotype distribution according  control and patient groups
Variable
Group
P Control      RA    Total
N % N % N %
Gender < 0.001
Male   62 59.6   26 12.5   88 28.2
Female   42 40.4 182 87.5 224 71.8
TCF7L2 genotype 0.07
CC   43 41.3   99 47.6 142 45.5
CT   45 43.3   94 45.2 139 44.6
TT   16 15.4   15   7.2   31   9.9
TCF7L2 genotype 0.296
CC   43 41.3   99 47.6 142 45.5
CT or TT   61 58.7 109 52.4 170 54.5
Total 104 100 208 100 312 100
Allele 0.069
C 131 63.0 292 70.2 423 67.8
T   77 37.0 124 29.8 201 32.2
Total 208 100 416 100 624 100
RA: rheumatoid arthritis.
Table 2 
Genotype distribution and correlation with smoking and 
indicators of disease severity in patients
Variable
TCF7L2 genotype
P   CC     CT     TT     Total
N % N % N % N %
Smoking 0.691
No 62 62.6 62 66.0 11 73.3 135 64.9
Yes 37 37.4 32 34.0   4 26.7   73 35.1
RF 0.418*
No 29 31.2 21 22.8   3 23.1   53 26.8
Yes 64 68.8 71 77.2 10 76.9 145 73.2
Erosions 0.261
No 54 56.3 48 51.1 11 73.3 113 55.1
Yes 42 43.8 46 48.9   4 26.7   92 44.9
Functional 
class 0.328*
I 44 44.4 30 31.9   6 40.0   80 38.5
II 25 25.3 36 38.3   6 40.0   67 32.2
III 18 18.2 21 22.3   2 13.3   41 19.7
IV 12 12.1   7   7.4   1   6.7   20   9.6
RF: rheumatoid factor. *Result of the Likelihood Ratio test.
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Table 3 




OR* CI (95%) OR** CI (95%) P       CC    CT or TT
N % N %
Smoking
No 62 62.6 73 67 1
Yes 37 37.4 36 33 0.83 0.47-1.46 0.81 0.44-1.48 0.485
RF
No 29 31.2 24 22.9 1
Yes 64 68.8 81 77.1 1.53 0.81-2.88 1.5 0.79-2.84 0.214
Erosions
No 54 56.3 59 54.1 1
Yes 42 43.8 50 45.9 1.09 0.63-1.89 1.13 0.65-1.98 0.668
Functional class
I 44 44.4 36 33 1
II 25 25.3 42 38.5 2.05 1.06-3.98 2.11 1.07-4.19 0.032
III 18 18.2 23 21.1 1.56 0.73-3.33 1.59 0.73-3.46 0.247
IV 12 12.1   8   7.3 0.81 0.3-2.21 0.8 0.27-2.31 0.675
RF: rheumatoid factor. *Not adjusted; **Adjusted by gender and age.
The data were also evaluated using the dominant model, in 
which carriers of the CT and TT genotype were grouped for lo-
gistic regression statistical analysis with gender and age controls 
(Table 3). A non-signifi cant increase was observed for the likely 
appearance of the T allele in patients positive for rheumatoid 
factor and erosions. However, in the analysis of the functional 
class status, there was an increase in the frequency of T allele 
in functional class II patients as compared to functional class I 
patients (P = 0.032). For other functional classes, a statistically 
signifi cant increase in the likely appearance of the polymorphism 
was not observed (P = 0.247 and P = 0.675 for class III and IV, 
respectively).
DISCUSSION
This was a pioneering study in the assessment of the associa-
tion between the CC genotype of the rs790146 polymorphism 
in the TCF7L2 gene and some features of RA.
Although an association between the rs7903146 polymor-
phism of the TCF7L2 gene and RA was not found, our results 
suggest a tendency, although not statistically signifi cant, that 
the T allele is less represented in the patient group than in the 
control group.
In this study, a non-signifi cant increase in the frequency of 
the C allele of the rs7903146 polymorphism in the TCF7L2 
gene was found in RA patients. A statistically relevant correla-
tion was observed between the T allele and functional class II 
of RA. The signifi cance of these fi ndings is uncertain, and it 
is possible that the small number of patients included in this 
study was a factor, as well as the fact that the control group 
was selected by convenience and was hence not matched to 
the patient group. 
To our knowledge, the allele frequencies of TCF7L2 
rs7903146 polymorphism have not been shown to vary accord-
ing to gender or ethnic groups, except in the Chinese popula-
tion, in which the allele T of the rs7903146 polymorphism 
was shown to be low.31 The allele frequencies found in the 
control group of present study are similar to those described in 
healthy individuals included in control groups of other studies 
involving this polymorphism. However, the gender and also 
the average age differences between patient and control groups 
in this study are recognized as important limitations, since 
RA is more common in women after the age of 40 years. This 
may have precluded fi nding possible genotypic differences 
between them.
This is the fi rst study, to the best of our knowledge, that 
has assessed the correlation between a TCF7L2 variant 
and a rheumatologic disease. Furthermore, it is the fi rst to 
demonstrate a polymorphism of this gene that is associated 
with a functional class status of RA. Although this study has 
many limitations, which prevent defi nite conclusions about 
the signifi cance of these fi ndings, it opens new avenues for 
the investigation of the physiopathology of RA. Additional 
studies are necessary, therefore, to confi rm these results and 
Mota et al.
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clarify the role of the TCF7L2 gene in the risk and determi-
nation of RA severity.
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